Evolution of homocysteine during ovarian stimulation for IVF or ICSI;Évolution de l'homocystéine lors d'un cycle d'induction ovarienne pour FIV ou ICSI

Gynecologie Obstetrique et Fertilite

Volumn 30, Issue 2, 2002, Pages 121-128

  Bettahar Lebugle, K ^a   Feugeas, O ^a   Wittemer, C ^a   Ohl, J ^a   Rongieres C ^a   Nisand, I ^a  

^a SIHCUS CMCO Centre Medico Chirurgical et Obstetrical   (France)

Author keywords

ART; Homocysteine; Ovarian stimulation

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; CHORIONIC GONADOTROPIN; CYANOCOBALAMIN; ESTRADIOL; FOLIC ACID DERIVATIVE; GONADORELIN AGONIST; HOMOCYSTEINE; GONADORELIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FERTILIZATION IN VITRO; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INTRACYTOPLASMIC SPERM INJECTION; MOLECULAR BIOLOGY; OVARY; OVULATION INDUCTION; PREVALENCE; RISK ASSESSMENT; SAMPLE SIZE; THROMBOSIS; BLOOD; DRUG POTENTIATION;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; OVULATION INDUCTION; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 0036481266     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(01)00278-8     Document Type: Article

References (45)

1. Upper limb thrombosis associated with assisted conception treatment
2. Diagnosis, prevention and management of ovarian hyperstimulation syndrome
3. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis
4. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
5. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance
6. Hormone replacement therapy may reduce high serum homocysteine in postmenopeusal women
7. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females
8. Relationship between homocysteine and thrombotic disease
9. Homocystéine et maladie thromboembolique veineuse: Une nouvelle approche du risque thrombotique veineux
10. Plasma homocysteine in venous thromboembolism
11. High prevalence of hyperhomocyst(e) inemia in patients with juvenile venous thrombosis
12. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease
13. Newborn screening for homocystinuria: Irish and world experience
14. Disorders of transulfuration
15. Molecular genetics methylenetetrahydrofolate reductase deficiency
16. Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis
17. Venous thromboembolic disease and prothrombin, methylene tetrahydrofolate reductase and factor V genes
18. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
19. Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits
20. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study
21. Hyperhomocysteinemia in chronic alcoholism: Correlation with folate, vitamin B-12 and vitamin B-6 status
22. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
23. Hyperhocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis
24. Résistance à la protéine C activée
25. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
26. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism
27. Association between activated protein C resistance and hyperhomocyst(e)inemia in juvenile venous thromboembolism [abstract]
28. Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation
29. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): A possible role of ovarian renin
30. The role of prostaglandins in ovarian hyperstimulation
31. Characterisation of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome
32. Does ovarian stimulation for in vitro fertilization induce a hypercoagulable state?
33. Response of blood coagulation parameters to elevated endogenous 17β œstradiol levels induced by human menopausal gonadotropins
34. Von Willebrand factor: An endothelial marker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome
35. The ovarian hyperstimulation syndrome
36. Severe ovarian hyperstimulation syndrome and deep venous thrombosis
37. The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzymz function
38. Les modifications hématologiques liées à la grossesse
39. Thromboembolic disease in pregnancy
40. Accidents thromboemboliques et gravidopuerpéralité
41. Grossesse et maladie thromboembolique
42. Hyperstimulation ovarienne et risque thrombogène
43. Ovarian hyperstimulation syndrome and thrombosis of the internal jugular vein
44. Syndrome d'hyperstimulation ovarienne et thrombose. À propos d'un cas de thrombose jugulaire interne. Revue de la littérature